Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Ochenduszko

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Folia Medica Cracoviensia|October 18, 2022
Medical students' perception of e-learning approach (MeSPeLA) - a mixed method researchMirosława Püsküllüoğlu, Michał Nowakowski, Sebastian Ochenduszko, et al.
Critical Reviews in Oncology/Hematology|July 18, 2024
Adjuvant anti-PD1 immunotherapy of resected skin melanoma: an example of non-personalized medicine with no overall survival benefitSebastian Ochenduszko, Miroslawa Puskulluoglu, Renata Pacholczak-Madej, et al.
Molecular and Clinical Oncology|April 18, 2017
Paraneoplastic limbic encephalitis in a patient with extensive disease small-cell lung cancerSebastian Ochenduszko, Bartosz Wilk, Joanna Dabrowska, et al.
Journal of Clinical Medicine|September 10, 2021
Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer PatientsKamil Konopka, Agnieszka Micek, Sebastian Ochenduszko, et al.
Therapeutic Advances in Medical Oncology|May 12, 2017
Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational studySebastian Ochenduszko, Mirosława Puskulluoglu, Kamil Konopka, et al.
Current Problems in Cancer|November 19, 2016
Evaluation of health-related quality of life and its main influencing factors in a Polish population of patients with bone metastasesMirosława Püsküllüoğlu, Aneta L Zygulska, Iwona M Tomaszewska, et al.
International Journal of Molecular Sciences|January 28, 2026
Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed?Rafał Becht, Kajetan Kiełbowski, Paulina Żukowska, et al.
Acta Dermatovenerologica Croatica : ADC|August 9, 2014
Assessment of skin-related toxicity in patients with metastatic colorectal cancer treated with cetuximabAgnieszka Pacek, Magdalena Kozioł, Mirosława Püsküllüoğlu, et al.
Contemporary Oncology (Poznan, Poland)|March 6, 2014
Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer - as measured by EORTC toolsKrzysztof A Tomaszewski, Mirosława Püsküllüoğlu, Katarzyna Biesiada, et al.
Applied Research in Quality of Life|August 8, 2014
Pilot Testing and Preliminary Psychometric Validation of the Polish Translation of the EORTC INFO25 Questionnaire: Validation of the Polish version of INFO25-pilot studyMirosława Püsküllüoğlu, Krzysztof A Tomaszewski, Aneta L Zygulska, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Folia Medica Cracoviensia|October 18, 2022
Medical students' perception of e-learning approach (MeSPeLA) - a mixed method researchMirosława Püsküllüoğlu, Michał Nowakowski, Sebastian Ochenduszko, et al.
Critical Reviews in Oncology/Hematology|July 18, 2024
Adjuvant anti-PD1 immunotherapy of resected skin melanoma: an example of non-personalized medicine with no overall survival benefitSebastian Ochenduszko, Miroslawa Puskulluoglu, Renata Pacholczak-Madej, et al.
Molecular and Clinical Oncology|April 18, 2017
Paraneoplastic limbic encephalitis in a patient with extensive disease small-cell lung cancerSebastian Ochenduszko, Bartosz Wilk, Joanna Dabrowska, et al.
Journal of Clinical Medicine|September 10, 2021
Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer PatientsKamil Konopka, Agnieszka Micek, Sebastian Ochenduszko, et al.
Therapeutic Advances in Medical Oncology|May 12, 2017
Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational studySebastian Ochenduszko, Mirosława Puskulluoglu, Kamil Konopka, et al.
Current Problems in Cancer|November 19, 2016
Evaluation of health-related quality of life and its main influencing factors in a Polish population of patients with bone metastasesMirosława Püsküllüoğlu, Aneta L Zygulska, Iwona M Tomaszewska, et al.
International Journal of Molecular Sciences|January 28, 2026
Immunotherapy in Head and Neck Cancer-Where Are We Now and Where Are We Headed?Rafał Becht, Kajetan Kiełbowski, Paulina Żukowska, et al.
Acta Dermatovenerologica Croatica : ADC|August 9, 2014
Assessment of skin-related toxicity in patients with metastatic colorectal cancer treated with cetuximabAgnieszka Pacek, Magdalena Kozioł, Mirosława Püsküllüoğlu, et al.
Contemporary Oncology (Poznan, Poland)|March 6, 2014
Main influencing factors and health-related quality of life issues in patients with oesophago-gastric cancer - as measured by EORTC toolsKrzysztof A Tomaszewski, Mirosława Püsküllüoğlu, Katarzyna Biesiada, et al.
Applied Research in Quality of Life|August 8, 2014
Pilot Testing and Preliminary Psychometric Validation of the Polish Translation of the EORTC INFO25 Questionnaire: Validation of the Polish version of INFO25-pilot studyMirosława Püsküllüoğlu, Krzysztof A Tomaszewski, Aneta L Zygulska, et al.
Pageof 3